18h
GlobalData on MSNGilead’s lenacapavir moves closer to FDA approval for HIV PrEP useThe US Food and Drug Administration (FDA) has accepted Gilead’s new drug application (NDA) for lenacapavir and set a prescription drug user fee act (PDUFA) target action date of ...
In a joint survey by Aidsfonds, GNP+ and the Robert Carr Fund 22% of organizations reported increased experiences of discrimination, including reports of discrimination within healthcare settings, ...
Preventing HIV infections could soon be as simple as two shots a year.
Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...
23h
Hosted on MSNFEATURED: Condoms remain top choice for preventing HIV — AIDS Healthcare FoundationCondoms are among the most effective methods for preventing the sexual transmission of HIV, according to the AIDS Healthcare Foundation (AHF) in Rwanda. AHF Rwanda offers comprehensive services, ...
Despite breakthroughs in HIV treatment and prevention worldwide, critical challenges such as stigma, unequal access and ...
If PEPFAR is not reauthorized for the next four years, and without other resources for the HIV response, there would be 6.3 ...
HIV is spread by bodily fluids such as blood, breast milk or semen. It gradually weakens the body's immune system and makes ...
With treatment, people living with HIV can have long and healthy lives. However, if left untreated, it can cause a weakened immune system or acquired immune deficiency syndrome (AIDS). Some people may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results